The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol

@article{Schep2012TheCT,
  title={The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol},
  author={L. Schep and K. Knudsen and R. Slaughter and J. A. Vale and B. M{\'e}garbane},
  journal={Clinical Toxicology},
  year={2012},
  volume={50},
  pages={458 - 470}
}
  • L. Schep, K. Knudsen, +2 authors B. Mégarbane
  • Published 2012
  • Medicine
  • Clinical Toxicology
    • Introduction. Gamma-hydroxybutyrate (GHB) and its precursors, gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD), are drugs of abuse which act primarily as central nervous system (CNS) depressants. In recent years, the rising recreational use of these drugs has led to an increasing burden upon health care providers. Understanding their toxicity is therefore essential for the successful management of intoxicated patients. We review the epidemiology, mechanisms of toxicity, toxicokinetics… CONTINUE READING
    View on Taylor & Francis
    bezoar.georgiapoisoncenter.org
    120 Citations
    Highly Influential Citations
    6
    Background Citations
    41
    Methods Citations
    1
    Results Citations
    1
    120 Citations
    Citation Type

    Citation Type

    Self-administration of gamma-hydroxybutyric acid (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons
    • 7
    Gamma-Butyrolactone Overdose Potentially Complicated by Co-Ingestion of Industrial Solvent N-Methyl-2-pyrrolidone.
    Physical dependence on gamma-hydroxybutrate (GHB) prodrug 1,4-butanediol (1,4-BD): time course and severity of withdrawal in baboons.
    • 8
    1,4-Butanediol overdose mimicking toxic alcohol exposure
    • 2
    Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention
    • 21
    Gamma-hydroxybutyrate abuse and dependence
    • 2
    The Use of Intravenous Baclofen as Therapy for the γ-hydroxybutyric Acid Withdrawal Syndrome
    • PDF
    Management and treatment of gamma butyrolactone withdrawal syndrome: a case report and review.
    • 13
    Gamma-hydroxybutyrate abuse: pharmacology and poisoning and withdrawal management
    • 1
    • PDF
    Treat γ-hydroxybutyrate (GHB) and γ-butyrolactone (GBL) dependence with benzodiazepines first, then with other approaches if benzodiazepine-resistant
    • 1

    References

    SHOWING 1-10 OF 357 REFERENCES
    Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: a case report and systematic review.
    • 84
    • PDF
    Acute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD).
    • 42
    Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: a case report and review of the literature.
    • 81
    Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD).
    • 52
    • PDF
    Adverse events, including death, associated with the use of 1,4-butanediol.
    • 218
    Treatment of a 1,4-Butanediol Poisoning with Fomepizole
    • 13
    The clinical development of gamma-hydroxybutyrate (GHB).
    • 12
    The Clinical Development of γ-Hydroxybutyrate (GHB)
    • 27
    Clinical Pharmacology of 1,4‐Butanediol and Gamma‐hydroxybutyrate After Oral 1,4‐Butanediol Administration to Healthy Volunteers
    • 50
    Physostigmine as a Treatment for Gamma-Hydroxybutyrate Toxicity: A Review
    • 30